"Si tenemos un paciente que tiene retinopata diabtica y va a utilizarse la semaglutida
these cutting-edge injections share many similarities, but they also have their own specificities
Wegovy (semaglutide) is a GLP-1 receptor agonist used for weight management in adults with obesity or overweight with comorbidities
All participants were on metformin at the maximum tolerated dose according to clinical and laboratory parameters (mean dose = 1500 mg), and none were taking other antihyperglycemic drugs including insulin analogues
[DOI] [PubMed] [Google Scholar] 18.Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T, REWIND Investigators Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
In clinical trials, semaglutide combined with lifestyle interventions has consistently proven effective in facilitating substantial weight loss, with many studies demonstrating an average loss of 15% after 1524 months